BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22626793)

  • 1. What improves minimal hepatic encephalopathy: probiotic yogurt, protein restriction or nonabsorbable disaccharides?
    Alfawaz HA; Aljumah AA
    Saudi J Gastroenterol; 2012; 18(3):153-4. PubMed ID: 22626793
    [No Abstract]   [Full Text] [Related]  

  • 2. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P; Sharma BC
    Saudi J Gastroenterol; 2012; 18(3):168-72. PubMed ID: 22626795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction.
    El-Karaksy HM; Afifi O; Bakry A; Kader AA; Saber N
    World J Pediatr; 2017 Feb; 13(1):70-75. PubMed ID: 27878780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disaccharides in the treatment of hepatic encephalopathy.
    Sharma P; Sharma BC
    Metab Brain Dis; 2013 Jun; 28(2):313-20. PubMed ID: 23456517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactulose Management of Minimal Hepatic Encephalopathy: A Systematic Review.
    Zucker DM; Redulla R
    Gastroenterol Nurs; 2019; 42(1):84-94. PubMed ID: 30688711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides.
    Morgan MY
    Metab Brain Dis; 2016 Dec; 31(6):1361-1364. PubMed ID: 27638474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonabsorbable disaccharides for hepatic encephalopathy.
    Als-Nielsen B; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2004; (2):CD003044. PubMed ID: 15106187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic Management of Hepatic Encephalopathy.
    Khalessi A; Pyrsopoulos NT
    Clin Liver Dis; 2024 May; 28(2):287-296. PubMed ID: 38548440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Old wine in new bottles: Lactulose works in hepatic encephalopathy].
    Bendtsen F
    Ugeskr Laeger; 2016 Oct; 178(42):. PubMed ID: 27745574
    [No Abstract]   [Full Text] [Related]  

  • 10. Beyond Lactulose: Treatment Options for Hepatic Encephalopathy.
    Gastroenterol Nurs; 2019; 42(3):E3-E4. PubMed ID: 31145254
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of hepatic encephalopathy: it's not lactulose.
    Shawcross DL; Jalan R
    BMJ; 2004 Jul; 329(7457):112; author reply 112. PubMed ID: 15242927
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy.
    Tapper EB
    JAMA Intern Med; 2015 May; 175(5):868. PubMed ID: 25938321
    [No Abstract]   [Full Text] [Related]  

  • 13. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy.
    Cutler T; Mints G
    JAMA Intern Med; 2015 May; 175(5):867-8. PubMed ID: 25938320
    [No Abstract]   [Full Text] [Related]  

  • 14. Can we ignore minimal hepatic encephalopathy any longer?
    Qadri AM; Ogunwale BO; Mullen KD
    Hepatology; 2007 Mar; 45(3):547-8. PubMed ID: 17326151
    [No Abstract]   [Full Text] [Related]  

  • 15. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
    Kalaitzakis E; Björnsson E
    Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
    [No Abstract]   [Full Text] [Related]  

  • 16. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy-Reply.
    Rahimi RS; Cuthbert JA; Rockey DC
    JAMA Intern Med; 2015 May; 175(5):868-9. PubMed ID: 25938322
    [No Abstract]   [Full Text] [Related]  

  • 17. ACP Journal Club. Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy.
    Kowdley KV; Burman BE
    Ann Intern Med; 2013 Oct; 159(8):JC8. PubMed ID: 24126669
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy.
    Sharma P; Sharma BC; Sarin SK
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):526-31. PubMed ID: 20009938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to dispel myths in the treatment of hepatic encephalopathy?
    Braillon A
    Nat Clin Pract Gastroenterol Hepatol; 2007 Oct; 4(10):E1; author reply E2. PubMed ID: 17909528
    [No Abstract]   [Full Text] [Related]  

  • 20. Should We Treat Minimal/Covert Hepatic Encephalopathy, and with What?
    Henderson PK; Herrera JL
    Clin Liver Dis; 2015 Aug; 19(3):487-95. PubMed ID: 26195203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.